Benzinga | Sep 22, 2020 07:09AM EDT

UBS Downgrades Illumina to Neutral, Lowers Price Target to $285

UBS analyst Dan Brennan downgrades Illumina (NASDAQ:ILMN) from Buy to Neutral and lowers the price target from $390 to $285.